Showing 1 - 15 results of 15 for search 'Mpagama, S', query time: 0.03s
Refine Results
-
1
-
2
-
3
HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania by Monica S Kahabuka, Yimtubezinash Woldeamanuel, Peter M. Mbelele, Emmanuel A. Mpolya, Stellah G. Mpagama, Jonas P. Kessy, Tsegahun Manyazewal
Published 2024-04-01
Article -
4
Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis by Sidamo T, Rao PS, Aklillu E, Shibeshi W, Park Y, Cho YS, Shin JG, Heysell SK, Mpagama SG, Engidawork E
Published 2022-11-01
Article -
5
Multiple pathogens contribute to human immunodeficiency virus-related sepsis in addition to Mycobacterium tuberculosis: A prospective cohort in Tanzania by Donatus Bonphace Tsere, Gabriel Mkilema Shirima, Brian S Grundy, Scott K Heysell, Stellah G Mpagama, Shabani Ramadhani Mziray, Peter M Mbelele
Published 2022-01-01
Article -
6
Burden, clinical features and outcomes of post-tuberculosis lung disease in sub-Saharan Africa: a protocol for a systematic review and meta-analysis by Mark J Siedner, Francis Bajunirwe, David B Meya, Lisa Liang Philpotts, Peggy S Lai, Joseph Baruch Baluku, Edwin Nuwagira, Stella G Mpagama
Published 2022-08-01
Article -
7
Levofloxacin pharmacokinetics/pharmacodynamics, dosing, susceptibility breakpoints, and artificial intelligence in the treatment of multidrug-resistant tuberculosis by Deshpande, D, Pasipanodya, JG, Mpagama, SG, Bendet, P, Srivastava, S, Koeuth, T, Lee, PS, Bhavnani, SM, Ambrose, PG, Thwaites, G, Heysell, SK, Gumbo, T
Published 2018Journal article -
8
Perception and Risk Factors Associated with Tuberculosis in the Manyara Region, Tanzania by Prudence Masanga, Sarapia Paul, Peter Mbelele, Peter Daud, Alphonce Liyoyo, Lidia Munuo, Samson Lyimo, Beatus Lyimo, Sreenidhi Srinivasan, Isabella Cattadori, Robab Katani, Vivek Kapur, Stella Mpagama, Joram Buza
Published 2023-10-01
Article -
9
“Honestly, this problem has affected me a lot”: a qualitative exploration of the lived experiences of people with chronic respiratory disease in Sudan and Tanzania by Uzochukwu Egere, Elizabeth H Shayo, Martha Chinouya, Miriam Taegtmeyer, Jane Ardrey, Stellah Mpagama, Nyanda Elias Ntinginya, Rana Ahmed, El Hafiz Hussein, Asma El Sony, Tom Wingfield, Angela Obasi, Rachel Tolhurst, The IMPALA Consortium
Published 2023-03-01
Article -
10
Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated... by Stellah G. Mpagama, Happiness C. Mvungi, Peter M. Mbelele, Hadija H. Semvua, Alphonce A. Liyoyo, Kristen Petros de Guex, Derek Sloan, Gibson S. Kibiki, Martin Boeree, Patrick P. J. Phillips, Scott K. Heysell
Published 2023-04-01
Article -
11
Experiences and perceptions of participants on the pathway towards clinical management of dual tuberculosis and diabetes mellitus in Tanzania by Nyasatu G. Chamba, Kenneth C. Byashalira, Dirk L. Christensen, Kaushik L. Ramaiya, Eliakimu P. Kapyolo, PendoMartha J. Shayo, Troels Lillebaek, Nyanda E. Ntinginya, Blandina T. Mmbaga, Ib C. Bygbjerg, Stellah G. Mpagama, Rachel N. Manongi
Published 2022-12-01
Article -
12
Introducing the ESAT-6 free IGRA, a companion diagnostic for TB vaccines based on ESAT-6. by Ruhwald, M, de Thurah, L, Kuchaka, D, Zaher, MR, Salman, AM, Abdel-Ghaffar, A-R, Shoukry, FA, Michelsen, SW, Soborg, B, Blauenfeldt, T, Mpagama, S, Hoff, ST, Agger, EM, Rosenkrands, I, Aagard, C, Kibiki, G, El-Sheikh, N, Andersen, P
Published 2017Journal article -
13
Whole-genome sequencing of SARS-CoV-2 isolates from symptomatic and asymptomatic individuals in Tanzania by Shabani Ramadhani Mziray, Shabani Ramadhani Mziray, Marco van Zwetselaar, Charles C. Kayuki, Peter M. Mbelele, Abel N. Makubi, Alex S. Magesa, Riziki M. Kisonga, Tolbert B. Sonda, Gibson S. Kibiki, George Githinji, George Githinji, Scott K. Heysell, Jaffu O. Chilongola, Jaffu O. Chilongola, Stellah G. Mpagama
Published 2023-01-01
Article -
14
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of differen... by A Dierig, M Hoelscher, S Schultz, L Hoffmann, A Jarchow-MacDonald, EM Svensson, L Te Brake, R Aarnoutse, M Boeree, TD McHugh, LM Wildner, X Gong, PPJ Phillips, LT Minja, N Ntinginya, S Mpagama, A Liyoyo, RS Wallis, M Sebe, FA Mhimbira, B Mbeya, M Rassool, L Geiter, YL Cho, N Heinrich
Published 2023-06-01
Article -
15
Clinical standards for drug-susceptible pulmonary TB by Akkerman, O. W., Duarte, R., Tiberi, S., Schaaf, H.S., Lange, C., Alffenaar, J.W.C., Denholm, J., Carvalho, A.C.C., Bolhuis, M.S., Borisov, S., Bruchfeld, J., Cabibbe, A.M., Caminero, J.A., Carvalho, I., Chakaya, J., Centis, R., Dalcomo, M.P., D'Ambrosio, L., Dedicoat, M., Dheda, K., Dooley, K.E., Furin, J., Garcia-Garcia, J.-M., van Hest, N.A.H., de Jong, B.C., Kurhasani, X., Martson, A.G., Mpagama, S., Munoz Torrico, M., Nunes, E., Ong, C.W.M., Palmero, D.J., Ruslami, R., Saktiawati, A.M.I., Semuto, C., Silva, D.R., Singla, R., Solovic, I., Srivastava, S., de Steenwinkel, J.E.M., Story, A., Sturkenboom, M.G.G., Tadolini, M., Udwadia, Z.F., Verhage, A.R., Zellweger, J.P., Migliori, G.B.
Published 2022
Article